Related Experiment Videos
Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis
Journal of Neurology, Neurosurgery, and Psychiatry
|July 24, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease.
Neurological research and practice·2020
Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases.
Neuropathology and applied neurobiology·2020
Recent silent infarcts do not increase the risk of haemorrhage after intravenous thrombolysis.
European journal of neurology·2020
MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.
Journal of neurology, neurosurgery, and psychiatry·2026
Prevalence, clinical characteristics and treatment response of tremor in chronic inflammatory demyelinating polyneuropathy.
Journal of neurology, neurosurgery, and psychiatry·2026
Whole-body quantitative muscle MRI in myotonic dystrophy type 2: a sensitive tool for pattern recognition, disease stratification and objective assessment of clinical severity.
Journal of neurology, neurosurgery, and psychiatry·2026
Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
Journal of neurology, neurosurgery, and psychiatry·2026
Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.
Journal of neurology, neurosurgery, and psychiatry·2026
Epilepsy and education: a nationwide cohort study.
Journal of neurology, neurosurgery, and psychiatry·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026